Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2014-04-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.00113-14PMID 24709254PMCID PMC4068439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HCV direct‐acting antiviral agents: the best interferon‐free combinations

  2014cited by this paper
• Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.

  2014cited by this paper
• Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A.

  2014cited by this paper
• Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection

  2014cited by this paper
• Epidemiology and natural history of HCV infection

  2013cited by this paper
• Modulation of Hepatitis C Virus Genome Encapsidation by Nonstructural Protein 4B

  2013cited by this paper
• Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein

  2013influential reference
• Understanding the hepatitis C virus life cycle paves the way for highly effective therapies

  2013cited by this paper
• Antiviral strategies in hepatitis C virus infection.

  2012cited by this paper
• Boceprevir for untreated chronic HCV genotype 1 infection.

  2011cited by this paper
• Boceprevir for Untreated Chronic HCV Genotype 1 Infection

  2011cited by this paper
• Telaprevir for previously untreated chronic hepatitis C virus infection.

  2011cited by this paper
• NS4B Self-Interaction through Conserved C-Terminal Elements Is Required for the Establishment of Functional Hepatitis C Virus Replication Complexes

  2011cited by this paper
• A Respiratory Syncytial Virus Replicon That Is Noncytotoxic and Capable of Long-Term Foreign Gene Expression

  2011cited by this paper
• New opportunities in anti-hepatitis C virus drug discovery: targeting NS4B.

  2011cited by this paper
• Identification of a Class of HCV Inhibitors Directed Against the Nonstructural Protein NS4B

  2010cited by this paper
• A small molecule inhibits HCV replication and alters NS4B's subcellular distribution.

  2010cited by this paper
• Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis

  2008cited by this paper
• The Hepatitis C Virus NS4B Protein Can trans-Complement Viral RNA Replication and Modulates Production of Infectious Virus

  2008cited by this paper
• Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

  2007cited by this paper
• Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

  2006influential reference
• Liquid-phase synthesis of combinatorial libraries based on 7-trifluoromethyl-substituted pyrazolo[1,5-a]pyrimidine scaffold.

  2005cited by this paper
• Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication.

  2005cited by this paper
• A Nucleotide Binding Motif in Hepatitis C Virus (HCV) NS4B Mediates HCV RNA Replication

  2004cited by this paper
• Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.

  2004cited by this paper
• Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

  2003cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.

  2003cited by this paper
• Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

  2003cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex

  2002cited by this paper
• Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus.

  2002cited by this paper
• Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo

  2002cited by this paper
• Modulation of the Hepatitis C Virus RNA-dependent RNA Polymerase Activity by the Non-Structural (NS) 3 Helicase and the NS4B Membrane Protein*

  2002cited by this paper
• The natural history of hepatitis C virus infection.

  2001cited by this paper
• Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome

  2000cited by this paper
• Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends

  2000cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000cited by this paper
• Natural history of hepatitis C virus infection

  2000cited by this paper
• Comparison of the Transcription and Replication Strategies of Marburg Virus and Ebola Virus by Using Artificial Replication Systems

  1999cited by this paper
• Hyperphosphorylation of the Hepatitis C Virus NS5A Protein Requires an Active NS3 Protease, NS4A, NS4B, and NS5A Encoded on the Same Polyprotein

  1999cited by this paper
• Modulation of Hepatitis C Virus NS5A Hyperphosphorylation by Nonstructural Proteins NS3, NS4A, and NS4B

  1999cited by this paper
• Noncytopathic Sindbis virus RNA vectors for heterologous gene expression.

  1998cited by this paper
• Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

  1997cited by this paper
• Biochemistry and clinical applications of ribavirin

  1986cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• In Vitro Determination of Antimicrobial, Antioxidant and Antiviral Properties of Greek Plant Extracts

  2025cites this paper
• Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights

  2024cites this paper
• Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors

  2022cites this paper
• Dengue Virus Replication Is Associated with Catecholamine Biosynthesis and Metabolism in Hepatocytes

  2022cites this paper
• Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.

  2020cites this paper
• In silico design and analysis of NS4B inhibitors against hepatitis C virus

  2020cites this paper
• Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species.

  2019cites this paper
• Evolution of HCV NS4B Inhibitors

  2019cites this paper
• Preclinical Evaluation of Amphihevir, a First-in-Class Clinical Hepatitis C Virus NS4B Inhibitor

  2019cites this paper
• Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus

  2018cites this paper
• HCV Drug Resistance

  2017cites this paper
• Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection

  2017cites this paper
• The HCV Replicase Complex and Viral RNA Synthesis

  2016cites this paper
• Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B.

  2016cites this paper
• PTC725, an NS4B-Targeting Compound, Inhibits a Hepatitis C Virus Genotype 3 Replicon, as Predicted by Genome Sequence Analysis and Determined Experimentally

  2016cites this paper
• A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates.

  2016cites this paper
• HCV‐infected cells and differentiation increase monocyte immunoregulatory galectin‐9 production

  2016cites this paper
• Current Drug Discovery for Anti-hepatitis C Virus Targeting NS4B.

  2016cites this paper
• 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B.

  2015cites this paper
• ACCURACY OF LIVER STIFFNESS MEASUREMENT USING FIBROSCAN ® TO PREDICT THE RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRAL INFECTION

  2015cites this paper
• Encoded Library Technology Screening of Hepatitis C Virus NS4B Yields a Small-Molecule Compound Series with In Vitro Replicon Activity

  2015cites this paper
• ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients

  2015cites this paper
• Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein

  2015cites this paper
• Identification and characterisation of small molecule inhibitors targeted to the hepatitis C virus NS2 autoprotease.

  2014cites this paper
• Scientifico disciplinare : MED 09 ACCURACY OF LIVER STIFFNESS MEASUREMENT USING FIBROSCAN ® TO PREDICT THE RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRAL INFECTION

  2014influential citation